Sp1081
WHAT'S NEW IN THE CARE OF PATIENTS WITH PORTAL HTN: BEYOND BAVENO VII
Date
May 9, 2023
Explore related products in the following collection:
Society: AASLD
Speakers
DC VA Medical center
Presenter
Tracks
Related Products
GLOBAL EPIDEMIOLOGY OF CIRRHOSIS: CHANGING ETIOLOGICAL BASIS AND DISEASE BURDEN BETWEEN FEMALES AND MALES
BACKGROUND: Cirrhosis is a major contributor of morbidity and mortality in patients with chronic liver disease globally…
TRANSJUGULAR INTRA HEPATIC PORTO SYSTEMIC SHUNT(TIPS) IN ADVANCED AGE;A NATIONAL DATABASE STUDY.
BACKGROUND: Cirrhosis is a major contributor of morbidity and mortality in patients with chronic liver disease globally…
HIGH COMPLIANCE OF AASLD CIRRHOSIS QUALITY MEASURES IS ASSOCIATED WITH IMPROVED OUTCOMES IN CIRRHOSIS WITH ACUTE VARICEAL BLEEDING: SINGAPORE NATIONWIDE AUDIT
BACKGROUND: Cirrhosis is a major contributor of morbidity and mortality in patients with chronic liver disease globally…
COMPARISON IN THE MANAGEMENT OF GASTRIC VARICEAL BLEEDING: ENDOSCOPIC VARICEAL LIGATION VERSUS TRANSJUGULAR INTRAHEPATIC PORTOSYSTEMIC SHUNT (TIPS) VERSUS BALLOON-OCCLUDED RETROGRADE TRANSVENOUS OBLITERATION (BRTO): A FOUR-YEAR NATIONAL COHORT ANALYSIS
BACKGROUND: Cirrhosis is a major contributor of morbidity and mortality in patients with chronic liver disease globally…
